Status:
RECRUITING
PACCELIO - FDG-PET Based Small Volume Accelerated Immuno Chemoradiotherapy in Locally Advanced NSCLC
Lead Sponsor:
TheraOp
Collaborating Sponsors:
AstraZeneca
Conditions:
Stage III Non-small Cell Lung Cancer
Locally Advanced
Eligibility:
All Genders
18+ years
Phase:
PHASE2
Brief Summary
Multinational, randomized, controlled, open-label, multicenter phase II trial. Eligible patients will be randomized in a ratio of 1:1 to Experimental Arm (FDG-PET-based small volume accelerated radiot...
Eligibility Criteria
No eligibility criteria provided.
Key Trial Info
Start Date :
July 1 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
June 1 2028
Estimated Enrollment :
110 Patients enrolled
Trial Details
Trial ID
NCT06102057
Start Date
July 1 2024
End Date
June 1 2028
Last Update
December 17 2025
Active Locations (11)
Enter a location and click search to find clinical trials sorted by distance.
1
Universitätsklinik Carl Gustav Carus der Technischen Universität Dresden
Dresden, Germany, 01307
2
Universitätsklinikum Essen - Klinik für Strahlentherapie
Essen, Germany, 45122
3
Medical Center - University Of Freiburg, Department of Radiation Oncology
Freiburg im Breisgau, Germany, 79106
4
Universitätsmedizin Göttingen, Department for Radiotherapy and Radiooncology
Göttingen, Germany, 37075